21
Zeppezauer Michael, Schoenberger Arno, Cebecauer Ladislav: Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases. Symbiotec Ges Zur Erforschung, September 1, 2004: EP1451220-A2

Peptides are proposed with antigenic or immunogenic determinants, which result from autoantibodies in the body fluids of patients, who are suffering from autoimmun diseases, in particular diseases of the rheumatic group as systemic lupus erythematosus (SLE), rheumatoid arthritis or systemic sclerosi ...


22

23
Zeppezauer Michael, Reiner Class: Use of histones for therapeutic purposes. Symbiotec, January 23, 2008: EP1879609-A2

The invention relates to the use of at least one human recombinant histone, especially at least one histone H1 subtype, and/or a therapeutic histone fraction as a basis for the treatment of thrombocytopenia.


24
Zeppezauer Michael, Gross Peter: Use of an active biological substance in abnormal cellular and viral membrane physiologies. Symbiotec, April 23, 2008: EP1912678-A2

An active biological substance is disclosed for use in abnormal cellular and viral membrane physiologies in human and mammal organisms. The active substance has diagnostic and/or therapeutic properties and contains or consists of at least one component selected from the group of substances including ...


25
Michael Zeppezauer, Peter Gross: Use of an Active Biological Substance in Abnormal Cellular and Viral Membrane Physiologies. Symbiotec Gesellschaft Zur Forschung Und Entwicklung Auf Dem Gebiet Der Biotechnologie Mbh, Kubotera & Associates, December 10, 2009: US20090304597-A1

An active biological substance is disclosed for use in abnormal cellular and viral membrane physiologies in human and mammal organisms. The active substance has diagnostic and/or therapeutic properties and contains or consists of at least one component selected from the group of substances including ...


26
Class Reiner, Zeppezauer Michael: Antimicrobial histone h1 compositions, kits, and methods of use thereof. Class Reiner, Zeppezauer Michael, Symbiotec, Philadelphia Health And Education Corporation, COLBY Gary D, February 15, 2001: WO/2001/010901

The invention includes antibiotic pharmaceutical compositions comprising eukaryotic histone H1 protein and methods of using eukaryotic histone H1 protein to kill or to inhibit the growth of microorganisms, including, but not limited to, human pathogenic bacteria. The invention further includes a euk ...


27
Zeppezauer Michael, Schönberger Arno, Cebecauer Ladislav: Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases. Symbiotec Gesellschaft Zur Erforschung Und Entwicklung Auf Dem Gebiete Der Biotechnology Mbh, Zeppezauer Michael, Schönberger Arno, Cebecauer Ladislav, PÄTZOLD Herbert, May 30, 2003: WO/2003/044054

Peptides are proposed with antigenic or immunogenic determinants, which result from autoantibodies in the body fluids of patients, who are suffering from autoimmun diseases, in particular diseases of the rheumatic group as systemic lupus erythematosus (SLE), rheumatoid arthritis or systemic sclerosi ...


28

29

30